Full Length Research Paper
References
|
Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF (2006). Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch. Intern. Med. 166(19):2081-2086. |
|
|
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF (2009). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 91(2):456-488. |
|
|
Bhathena RK (2011). Insulin resistance and the long-term consequences of polycystic ovary syndrome. J. Obstet. Gynaecol. 31:105-110. |
|
|
Bickerton AS, Clark N, Meeking D, Shaw KM, Crook M, Lumb 2P, Turner C, Cummings MH (2005). Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J. Clin. Pathol. 58(2):151-154. |
|
|
Carmina E, Oberfield SE, Lobo RA (2010). The diagnosis of polycystic ovary syndrome in adolescents. Am. J. Obstet. Gynecol. 203(3):201-e1 |
|
|
Corbould A (2008). Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? Panminerva medica. 50(4):279-294. |
|
|
Dale PO, Tanbo T, Vaaler S, Abyholm T (1992). Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil. Steril. 58(3):487-491. |
|
|
Ehrmann DA (2005). Polycystic ovary syndrome. N. Engl. J. Med. 352(12):1223-1236. |
|
|
Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN (2006). Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metabol. 91(1):48-53. |
|
|
Fr DD, Tarlatzis R (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81(1). |
|
|
Herter LD, Golendziner E, Flores JA, Becker E Jr, Spritzer PM (2002). Ovarian and uterine sonography in healthy girls between 1 and 13 years old: correlation of findings with age and pubertal status. Am. J. Roentgenol. 178(6):1531-1536. |
|
|
Holte J, Bergh T, Berne C, Lithell H (1994). Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin. Endocrinol. 41(4):463-471. |
|
|
Karakelides H, Irving BA, Short KR, O'brien P, Nair KS (2010). Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes 59(1):89-97. |
|
|
Leibel NI, Baumann EE, Kocherginsky M, Rosenfield RL (2006). Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J. Clin. Endocrinol. Metab. 91:1275. |
|
|
Liang SJ, Liou TH, Lin HW, Hsu CS, Tzeng CR, Hsu MI (2012). Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome. Acta obstetricia et gynecologica Scandinavica. 91(10):1167-1172. |
|
|
Livadas S, Kollias A, Panidis D, Diamanti-Kandarakis E (2014). Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome. Eur. J. Endocrinol. 171(3):301-309. |
|
|
Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R (2008). Use of metformin in polycystic ovary syndrome. Am. J. Obstet. Gynecol.199:596-609. |
|
|
Miller WL, Geller DH, Rosen M (2006). Ovarian and adrenal androgen biosynthesis and metabolism. Androgen Excess Disorders in Women. pp. 19-33. |
|
|
Moran C, Arriaga M, Rodriguez G, Moran S (2012). Obesity differentially affects phenotypes of polycystic ovary syndrome. Int. J. Endocrinol. (1):1-7. |
|
|
Moran C, Renteria JL, Moran S, Herrera J, Gonzalez S, Bermudez JA (2008). Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome. Fertil. steril. 90(6):2310-2317. |
|
|
Moran LJ, Misso ML, Wild RA, Norman RJ (2010). Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reprod. Update 16(4):347-363. |
|
|
Panidis D, Tziomalos K, Macut D, Delkos D, Betsas G, Misichronis G, Katsikis I (2012). Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome. Fertil. Steril. 97:494-500. |
|
|
Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Patwardhan VM, Ghanghas R (2012). Hormonal Profile of Polycystic Ovary Syndrome (PCOS) In Indian Women. Res. J. Pharm. Biol. Chem. Sci. 3(4):1159-1172. |
|
|
Saxena P, Prakash A, Nigam A, Mishra A (2012). Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index. Ind. J. Endocrinol. Metab. 16(6):996-999. |
|
|
Spencer JB, Klein M, Kumar A, Azziz R (2007). The age-associated decline of androgens in reproductive age and menopausal Black and White women. J. Clin. Endocrinol. Metab. 92:4730-4733. |
|
|
Stovall DW, Bailey AP, Pastore LM(2011). Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome. J. Women's Health 20(1):37-43. |
|
|
Tsikouras P, Spyros L, Manav B, Zervoudis S, Poiana C, Nikolaos T, Petros P, Dimitraki M, Koukouli C, Galazios G(2015). Features of polycystic ovary syndrome in adolescence. J. Med. Life 8(3):291. |
|
|
Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D (2013). Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome. Human Reprod. 28(3):785-793. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
